发明人沈红梅,唐晓军,韩伟. "Method for the Synthesis of Tadalafil-13C2,d3" [P]. 中国发明专利, 专利号 CN 108625021 A, 授权公告日 2018-03-16.
发明人郑宇鹏,沈红梅,韩伟. "A Process for Preparing High-Purity Tadalafil-13C2,d3" [P]. 中国发明专利, 专利号 CN 112635449 A, 授权公告日 2022-01-06.
参考文献 Literature
O'Brien K, Kennedy M L. "Development and Validation of an LC-MS/MS Method for the Determination of 他达拉非-13C2,d3 in Pharmaceutical Formulations". J. Pharm. Biomed. Anal., 2010, 744, (3), 2535-2549.
Brown R C, Davis S M. "A Stability-Indicating HPLC Method for the Separation and Quantification of 他达拉非-13C2,d3 as an Impurity". Talanta, 2021, 504, 8183-8186.
Fischer P, Wagner E. "Identification and Structural Characterization of a Novel Degradation Product of Tadalafil-13C2,d3 Using HRMS and NMR". Anal. Chem., 2015, 1181, 2176-2182.
Yang F, Sun W, Liu J. "Forced Degradation Studies to Evaluate 他达拉非-13C2,d3 Profile in Drug Substances According to ICH Guidelines". Chromatographia, 2019, 1867, 5115-5138.